prescription drugs

Access to expensive drugs: greater demand, improved transparency

Each weekday, staff at the Exceptional Access Program (EAP) of the Ontario Ministry of Health and Long-Term Care receive between 250 and 300 requests for special prescription medications. These prescription drugs—typically expensive medications that are felt to be cost effective only when used to treat selected patients with specific problems—are not on the province’s regular

Health Canada and the FDA: two peas from different pods

John Greiss Healthy Debate blogger

Health Canada’s Health Products and Food Branch has a mandate of “minimizing health risk factors to Canadians while maximizing the safety provided by the regulatory system for health products”. The FDA’s mandate is “protecting the public health by assuring that… human and veterinary drugs, and vaccines and other biological products and medical devices intended for

Generic drug prices in Alberta: a step in the right direction

Michael Law healthydebate.ca blogger

Want to buy a $100 coffee? Sounds absurd, doesn’t it? However, it’s equally absurd that this is how much more Albertans pay for some generic drugs than people in other countries. Take, for instance, 20mg of the cholesterol-lowering drug simvastatin. Albertans pay 90 cents for each tablet. In New Zealand, the government drug plan buys the

Why do doctors still think pharma doesn’t influence them?

Ritika Goel Healthydebate.ca blogger

Why do so many doctors still think they are invincible to the influence of the pharmaceutical industry? Attractive, well-dressed, charismatic drug reps with pearly smiles and shiny flow charts still wait in waiting rooms. Lectures and conferences still occur where lunch is paid for by the pharmaceutical industry. Research studies are still published where investigators receive grants

Retail pharmacy evolution beset by implementation challenges

Retail pharmacy evolution beset by implementation challenges

Reforms to the way that Ontario community pharmacies are compensated for professional services, combined with an expanded scope of practice for pharmacists, are presenting major adjustment and implementation challenges for the profession. The changes are part of a culture change ushered in by a general shift in health care towards a push for greater inter-professional

The jury is in: time to fill Medicare’s prescription

Steve Morgan Healthydebate.ca blogger

Canada is the only country in the world that provides universal public insurance for medical and hospital care but not for prescription drugs. Is this a desirable divide in health policy or a failing of our health care system? If the latter, what would our system ideally look like? In an effort to answer this

Single-payer pharmacare would save billions

Steve Morgan Healthydebate.ca blogger

In my last blog post, I argued that to overcome the insurance market failures in health care the government must either provide universal public health insurance or tightly regulate the private insurance market. Here I explain why a single-payer universal system won’t bankrupt the health care system. Indeed, it will do the opposite. Reducing administrati​ve

Dangerous drug interactions and how to stop them

Lisa Priest Personal Health Navigator Sunnybrook healthydebate.ca

The Personal Health Navigator is available to all Canadian patients. Questions about your doctor, hospital or how to navigate the health care system can be sent to AskLisa@Sunnybrook.ca The Question: My mother is on six different medications from different pharmacies under the care of three specialists. How do I avoid a dangerous drug interaction? The Answer: This is

“Insurance” can’t fix Canada’s pharmacare problem

Steve Morgan Healthydebate.ca blogger

In my last post, I explained how Canadian provinces are moving toward a model of “catastrophic” drug coverage instead of a pharmacare model more comparable to our “Medicare” system. Depending on the province, public coverage against catastrophic drug costs means that patients must pay between 3% and 10% of their household income before any public

Canadian pharmacare: an ongoing failure

Steve Morgan Healthydebate.ca blogger

At this time of year, most Canadians are stocking up for the holidays. But a surprising number will also be stocking up on prescription drugs. This is not because they believe in doomsday predictions or because they are abusing the health care system. It is because, for a growing number of Canadians, prescription drug coverage only kicks

Can Canada pay less for generic drugs?

Can Canada pay less for generic drugs?

Generic drugs may seem cheap, at least in comparison to brand name drugs. But Canadians pay more for generic drugs than people who live in many other countries. Last summer, the premiers of several provinces announced that they would attempt to take advantage of competition between generic manufacturers to drive down prices. The generic manufacturers’

Provinces must stand together on drug purchases

private drug plans

At the recent Council of the Federation meeting, Canadian provinces (except Quebec) announced that they will begin bulk-buying different generic drugs to reduce health care costs.  They also flagged the need to both expand and accelerate group pricing on brand name pharmaceuticals. This is a long time coming and a step in the right direction. 

It is time to support the pharmaceutical industry

Doug Coyle Pharmaceutical Industry Drug Costs

When I present my research, a question I often get asked is “When will Canada support the pharmaceutical industry?”  What do they mean? With sales of $41.3 billion in 2009 and net revenues of $1.3 billion, the industry would in all accounts appear healthy. Furthermore, employment in the pharmaceutical industry has increased by 12% in

OxyNEO: pain relief or advertising addiction?

Shelagh McRae www.healthydebate.ca blogger

The patent on OxyContin has run out, the expected profit gone. Is it a coincidence that Purdue has stopped making it and replaced it with the new and improved OxyNEO? If Purdue can get Canadian doctors to prescribe it, their profits will continue. In a recent edition of the Medical Post, an industry-funded newspaper which goes

Medication shortages: how Ontario came to rely on one manufacturer

drug shortages sandoz health care health care policy

Concerns about quality and a fire at a Sandoz plant in Quebec exacerbated the current drug shortage in Canada. Many are asking why the shutdown of a single facility could threaten the nation’s supply of vital prescription medications. While federal and provincial governments have been eager to play the blame game, a shared sense of

How Ontario could pay less for drugs

Doug Coyle Pharmaceutical Industry Drug Costs

In an old episode of the Simpsons, Homer walks into a car lot and announces how much money he has to spend.  After, a highly gratified dealer quickly inverts a 6 into a 9, a deal is made and off Homer goes to face further mishaps.   This scene clearly illustrates how a consumer will always

The trouble with drug reps – perspectives from a medical resident

Bram Rochwerg healthydebate.ca Blogger

“What’s the harm in taking something small? It’s just a pen. It’s only lunch. It was just one weekend at the bed & breakfast with my partner. And I learned about a topic that I wouldn’t have known about otherwise. Plus I got some samples in return! It won’t affect my prescribing habits…” These are

National pharmacare: who are the winners and losers?

The Canada Health Act includes public coverage of services provided in hospitals and by doctors, but not prescription medications taken outside of hospital. Most provincial drug plans do provide some public coverage, but many Canadians lack drug coverage. In the last 25 years, prescription medications have become both more important and more expensive. Bringing prescription